SCHEMBL6975775

SCHEMBL6975775

CCN(C[NH])C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 4/20 0.43
ADH1C P00326 3/20 0.43
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.35
SIGMAR1 Q99720 2/20 0.34
TMEM97 Q5BJF2 1/20 0.34
EBP Q15125 1/20 0.34
HPGD P15428 1/20 0.33
PHGDH O43175 1/20 0.32
CYP2D6 P10635 3/20 0.32
CYP2C9 P11712 2/20 0.32
HSD17B10 Q99714 1/20 0.32
TSHR P16473 1/20 0.32
LTA4H P09960 1/20 0.31
SHBG P04278 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976297 0.98 ADH1A (0.40) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
SCHEMBL6964243 0.87
SCHEMBL150343 0.85 ADH1A (0.50) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
SCHEMBL28388990 0.85 ADH1A (0.50) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
SCHEMBL611858 0.85 ADH1A (0.50) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
SCHEMBL23073672 0.85 ADH1A (0.50) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
SCHEMBL612572 0.85 ADH1A (0.50) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
SCHEMBL356022 0.85 ADH1A (0.50) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
SCHEMBL613463 0.85 ADH1A (0.50) ADH1AADH1CALDH1A1SMN1; SMN2MEN1
Fluoride SCHEMBL9620456 0.82 ADH1A (0.48) ADH1AADH1CALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0870765-B1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARM CO LTD (JP) 2003-11-19 EP disclosed
US-5981557-A HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-11-09 US disclosed
EP-0870765-A1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARMACEUTICAL CO., LTD. (JP) 1998-10-14 EP disclosed